Clinical Trials Logo
  1. Home
  2. Overweight
  3. NCT00875511
  4. Details
NCT00875511 Clinical Trial

Effects of a Computer Game on Activity Choices

Overweight Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00875511
Other study ID # Study #3480
Secondary ID
Status Completed
Phase N/A
First received April 2, 2009
Last updated June 25, 2010
Start date November 2008
Est. completion date September 2009

Study information
Verified date April 2009
Source University at Buffalo
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The study seeks to discover whether peer rejection increases the value of food relative to peer interaction in overweight individuals. After playing a computer game that randomly simulates peer rejection or peer acceptance, participants will play another computer game that will assess the value of food and social interactions.

Overweight individuals may be more likely to resort to food in moments of distress and less likely to choose to interact with a peer to reestablish their sense of belongingness.

Recruitment information / eligibility
Status Completed
Enrollment 40
Est. completion date September 2009
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- Adults ages 18-50

- Adults with a BMI greater than or equal to 18.5

- Adults must report at least a moderate liking of study foods used

Exclusion Criteria:

- Adults should have no psychopathology

- Adults should have no developmental disabilities

- Adults should have no cold or upper respiratory distress that could influence their activities

- Adults should have not be taking medications that could affect their food intake

- Adults should have no dietary restrictions

- Adults should have no food allergies

Study Design

N/A

Related Conditions & MeSH terms

Locations
Country Name City State
United States University at Buffalo, Division of Behavioral Medicine Buffalo New York

Sponsors (1)
Lead Sponsor Collaborator
University at Buffalo

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary amount of food chosen amount of social time chosen No
See also
  Status Clinical Trial Phase
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Terminated NCT03299881 - Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss N/A
Completed NCT02805478 - Fat-Associated Cardiovascular Organ Dysfunction
Active, not recruiting NCT02558920 - Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
Completed NCT03759743 - Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject N/A
Completed NCT03610958 - Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss. N/A
Completed NCT03678766 - CHARGE: Controlling Hunger and ReGulating Eating N/A
Completed NCT04430465 - Effects of Wholegrains on Children's Health (KORN) N/A
Completed NCT04117802 - Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome N/A
Completed NCT05376865 - Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers N/A
Completed NCT03625427 - Effect of Palmitoleic Acid on C-reactive Protein N/A
Active, not recruiting NCT03435445 - Online Platform for Healthy Weight Loss (POEmaS) N/A
Enrolling by invitation NCT05576116 - Combined Bariatric Surgery and Pancreas After Kidney Transplantation for Type II Diabetics N/A
Recruiting NCT05249465 - Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention N/A
Active, not recruiting NCT06023095 - A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities Phase 1
Completed NCT03648892 - Brain Dopamine Function in Human Obesity Early Phase 1
Not yet recruiting NCT05751993 - Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive Interventions N/A
Recruiting NCT02887950 - Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause N/A
Terminated NCT02743598 - Liraglutide for HIV-associated Neurocognitive Disorder Phase 4
Terminated NCT02796144 - MEtformin and Lorcaserin for WeighT Loss in Schizophrenia Phase 4